1
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Eimer S, Belaud-Rotureau M-A, Airiau K,
Jeanneteau M, Laharanne E, Véron N, Vital A, Loiseau H, Merlio JP
and Belloc F: Autophagy inhibition cooperates with erlotinib to
induce glioblastoma cell death. Cancer Biol Ther. 11:1017–1027.
2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gudinaviciene I, Pranys D and Juozaityte
E: Impact of morphology and biology on the prognosis of patients
with gliomas. Medicina (Kaunas). 40:112–120. 2004.
|
4
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al; European Organisation for Research and Treatment of
Cancer Brain Tumor and Radiotherapy Groups; National Cancer
Institute of Canada Clinical Trials Group. Radiotherapy plus
concomitant and adjuvant temozolomide for glioblastoma. N Engl J
Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Fine HA, Dear KB, Loeffler JS, Black PM
and Canellos GP: Meta-analysis of radiation therapy with and
without adjuvant chemotherapy for malignant gliomas in adults.
Cancer. 71:2585–2597. 1993. View Article : Google Scholar : PubMed/NCBI
|
6
|
Appert-Collin A, Hubert P, Crémel G and
Bennasroune A: Role of ErbB receptors in cancer cell migration and
invasion. Front Pharmacol. 6:2832015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lund-Johansen M, Bjerkvig R, Humphrey PA,
Bigner SH, Bigner DD and Laerum OD: Effect of epidermal growth
factor on glioma cell growth, migration, and invasion in vitro.
Cancer Res. 50:6039–6044. 1990.PubMed/NCBI
|
8
|
Nishikawa R, Ji XD, Harmon RC, Lazar CS,
Gill GN, Cavenee WK and Huang HJ: A mutant epidermal growth factor
receptor common in human glioma confers enhanced tumorigenicity.
Proc Natl Acad Sci USA. 91:7727–7731. 1994. View Article : Google Scholar : PubMed/NCBI
|
9
|
Li B, Chang CM, Yuan M, McKenna WG and Shu
HK: Resistance to small molecule inhibitors of epidermal growth
factor receptor in malignant gliomas. Cancer Res. 63:7443–7450.
2003.PubMed/NCBI
|
10
|
Chang CY, Kuan YH, Ou YC, Li JR, Wu CC,
Pan PH, Chen WY, Huang HY and Chen CJ: Autophagy contributes to
gefitinib-induced glioma cell growth inhibition. Exp Cell Res.
327:102–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Chang CY, Shen CC, Su HL and Chen CJ:
Gefitinib induces apoptosis in human glioma cells by targeting Bad
phosphorylation. J Neurooncol. 105:507–522. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Rich JN, Reardon DA, Peery T, Dowell JM,
Quinn JA, Penne KL, Wikstrand CJ, Van Duyn LB, Dancey JE, McLendon
RE, et al: Phase II trial of gefitinib in recurrent glioblastoma. J
Clin Oncol. 22:133–142. 2004. View Article : Google Scholar
|
13
|
Agarwal S, Sane R, Gallardo JL, Ohlfest JR
and Elmquist WF: Distribution of gefitinib to the brain is limited
by P-glycoprotein (ABCB1) and breast cancer resistance protein
(ABCG2)-mediated active efflux. J Pharmacol Exp Ther. 334:147–155.
2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhao L, Yang G, Shi Y, Su C and Chang J:
Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles
for overcoming the drug acquired resistance. J Nanobiotechnology.
13:572015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zou ZZ, Nie PP, Li YW, Hou BX, Rui-Li, Shi
XP, Ma ZK, Han BW and Luo XY: Synergistic induction of apoptosis by
salinomycin and gefitinib through lysosomal and mitochondrial
dependent pathway overcomes gefitinib resistance in colorectal
cancer. Oncotarget. Oct 5–2015.(Epub ahead of print). View Article : Google Scholar
|
16
|
Wang G, Li X, Huang F, Zhao J, Ding H,
Cunningham C, Coad JE, Flynn DC, Reed E and Li QQ: Antitumor effect
of beta-elemene in non-small-cell lung cancer cells is mediated via
induction of cell cycle arrest and apoptotic cell death. Cell Mol
Life Sci. 62:881–893. 2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ding XF, Shen M, Xu LY, Dong JH and Chen
G: 13,14-bis(cis-3,5-dimethyl-1-piperazinyl)-β-elemene, a novel
β-elemene derivative, shows potent antitumor activities via
inhibition of mTOR in human breast cancer cells. Oncol Lett.
5:1554–1558. 2013.PubMed/NCBI
|
18
|
Yu Z, Wang R, Xu L, Xie S, Dong J and Jing
Y: β-Elemene piperazine derivatives induce apoptosis in human
leukemia cells through downregulation of c-FLIP and generation of
ROS. PLoS One. 6:e158432011. View Article : Google Scholar
|
19
|
Li X, Wang G, Zhao J, Ding H, Cunningham
C, Chen F, Flynn DC, Reed E and Li QQ: Antiproliferative effect of
beta-elemene in chemoresistant ovarian carcinoma cells is mediated
through arrest of the cell cycle at the G2-M phase. Cell Mol Life
Sci. 62:894–904. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ
and Xu YH: Anti-tumor effect of beta-elemene in glioblastoma cells
depends on p38 MAPK activation. Cancer Lett. 264:127–134. 2008.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Wu XS, Xie T, Lin J, Fan HZ, Huang-Fu HJ,
Ni LF and Yan HF: An investigation of the ability of elemene to
pass through the blood-brain barrier and its effect on brain
carcinomas. J Pharm Pharmacol. 61:1653–1656. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Alvarez-García V, González A,
Alonso-González C, Martínez-Campa C and Cos S: Regulation of
vascular endothelial growth factor by melatonin in human breast
cancer cells. J Pineal Res. 54:373–380. 2013.
|
23
|
Lu X, Wang Y, Luo H, Qiu W, Han H, Chen X
and Yang L: β-elemene inhibits the proliferation of T24 bladder
carcinoma cells through upregulation of the expression of Smad4.
Mol Med Rep. 7:513–518. 2013.
|
24
|
Liu J, Zhang Y, Qu J, Xu L, Hou K, Zhang
J, Qu X and Liu Y: β-Elemene-induced autophagy protects human
gastric cancer cells from undergoing apoptosis. BMC Cancer.
11:1832011. View Article : Google Scholar
|
25
|
Zhao YS, Zhu TZ, Chen YW, Yao YQ, Wu CM,
Wei ZQ, Wang W and Xu YH: β-elemene inhibits Hsp90/Raf-1 molecular
complex inducing apoptosis of glioblastoma cells. J Neurooncol.
107:307–314. 2012. View Article : Google Scholar
|
26
|
Liu S, Zhou L, Zhao Y and Yuan Y:
β-elemene enhances both radiosensitivity and chemosensitivity of
glioblastoma cells through the inhibition of the ATM signaling
pathway. Oncol Rep. 34:943–951. 2015.PubMed/NCBI
|
27
|
Zhao Q, Kretschmer N, Bauer R and Efferth
T: Shikonin and its derivatives inhibit the epidermal growth factor
receptor signaling and synergistically kill glioblastoma cells in
combination with erlotinib. International journal of cancer Int J
Cancer. 137:1446–1456. 2015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zhu T, Li X, Luo L, Wang X, Li Z, Xie P,
Gao X, Song Z, Su J and Liang G: Reversion of malignant phenotypes
of human glioblastoma cells by β-elemene through β-catenin-mediated
regulation of stemness-, differentiation- and
epithelial-to-mesenchymal transition-related molecules. J Transl
Med. 13:3562015. View Article : Google Scholar
|
29
|
Sun Y, Liu G, Zhang Y, Zhu H, Ren Y and
Shen YM: Synthesis and in vitro anti-proliferative activity of
beta-elemene monosubstituted derivatives in HeLa cells mediated
through arrest of cell cycle at the G1 phase. Bioorg Med Chem.
17:1118–1124. 2009. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yu Z, Wang R, Xu L, Dong J and Jing Y:
N-(beta-Elemene-13-yl) tryptophan methyl ester induces apoptosis in
human leukemia cells and synergizes with arsenic trioxide through a
hydrogen peroxide dependent pathway. Cancer Lett. 269:165–173.
2008. View Article : Google Scholar : PubMed/NCBI
|
31
|
Yao YQ, Xu YH, Lu J, Zhou HY and Wang YZ:
Effect of p38 MAPK on elemene-induced cell cycle arrest in C6
glioblastoma cells. Zhonghua Yi Xue Za Zhi. 88:56–58. 2008.(In
Chinese). PubMed/NCBI
|
32
|
Zhou J, Du T, Li B, Rong Y, Verkhratsky A
and Peng L: Crosstalk between MAPK/ERK and PI3K/AKT signal pathways
during brain ischemia/reperfusion. ASN Neuro. 7:72015. View Article : Google Scholar
|
33
|
Liu Q, Xu X, Zhao M, Wei Z, Li X, Zhang X,
Liu Z, Gong Y and Shao C: Berberine induces senescence of human
glioblastoma cells by downregulating the EGFR-MEK-ERK signaling
pathway. Mol Cancer Ther. 14:355–363. 2015. View Article : Google Scholar
|
34
|
Zhan YH, Liu J, Qu XJ, Hou KZ, Wang KF,
Liu YP and Wu B: β-Elemene induces apoptosis in human renal-cell
carcinoma 786-0 cells through inhibition of MAPK/ERK and PI3K/ Akt/
mTOR signalling pathways. Asian Pac J Cancer Prev. 13:2739–2744.
2012. View Article : Google Scholar
|
35
|
Li QQ, Wang G, Reed E, Huang L and Cuff
CF: Evaluation of cisplatin in combination with β-elemene as a
regimen for prostate cancer chemotherapy. Basic Clin Pharmacol
Toxicol. 107:868–876. 2010.PubMed/NCBI
|
36
|
Li QQ, Wang G, Huang F, Banda M and Reed
E: Antineoplastic effect of beta-elemene on prostate cancer cells
and other types of solid tumour cells. J Pharm Pharmacol.
62:1018–1027. 2010. View Article : Google Scholar : PubMed/NCBI
|
37
|
Wang CF, Fan L, Tian M, Qi XS, Liu JX,
Feng JB, Du SS, Su X and Wang YY: Radiosensitizing effect of
schinifoline from Zanthoxylum schinifolium Sieb et Zucc on human
non-small cell lung cancer A549 cells: A preliminary in vitro
investigation. Molecules. 19:20128–20138. 2014. View Article : Google Scholar : PubMed/NCBI
|
38
|
Li CL, Chang L, Guo L, Zhao D, Liu HB,
Wang QS, Zhang P, Du WZ, Liu X, Zhang HT, et al: β-elemene induces
caspase-dependent apoptosis in human glioma cells in vitro through
the upregulation of Bax and Fas/ FasL and downregulation of Bcl-2.
Asian Pac J Cancer Prev. 15:10407–10412. 2014. View Article : Google Scholar
|
39
|
Shi JM, Bai LL, Zhang DM, Yiu A, Yin ZQ,
Han WL, Liu JS, Li Y, Fu DY and Ye WC: Saxifragifolin D induces the
interplay between apoptosis and autophagy in breast cancer cells
through ROS-dependent endoplasmic reticulum stress. Biochem
Pharmacol. 85:913–926. 2013. View Article : Google Scholar : PubMed/NCBI
|
40
|
Maiuri MC, Zalckvar E, Kimchi A and
Kroemer G: Self-eating and self-killing: Crosstalk between
autophagy and apoptosis. Nat Rev Mol Cell Biol. 8:741–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Guan C, Liu W, Yue Y, Jin H, Wang X and
Wang XJ: Inhibitory effect of β-elemene on human breast cancer
cells. Int J Clin Exp Pathol. 7:3948–3956. 2014.
|
42
|
Thyagarajan A, Jedinak A, Nguyen H, Terry
C, Baldridge LA, Jiang J and Sliva D: Triterpenes from Ganoderma
Lucidum induce autophagy in colon cancer through the inhibition of
p38 mitogen-activated kinase (p38 MAPK). Nutr Cancer. 62:630–640.
2010. View Article : Google Scholar : PubMed/NCBI
|